ImaginAb Executes New License and Supply Agreement for CD8 ImmunoPET Technology with Leucid Bio
ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPETTM) imaging agent and radiopharmaceutical therapies (RPT), is pleased to announce the…
Read More...
Read More...